China Plastic Price Index (July 1-7
J Hematol Oncol: PD-1 monoclonal antibody---the efficacy and safety of geptanolimab injection (geptanolimab) in peripheral T-cell lymphoma (PTCL
Has the pork price bottomed out from Level 3 to Level 1 warning
45 medicines
J Clin Oncol: The perioperative addition of duvacizumab in patients with advanced NSCLC significantly increased the 1-year EFS rate
JCEM: Cardiometabolic Outcomes and Mortality in Patients with Adrenal Adenoma
my country's first self-operated deep-water large gas field "Shenhai No. 1" was completed and put into production
CRISPR gene editing to knock out PD-1 improved ready-to-use CAR-T therapy enters clinical trials
ADA Diabetes Diagnosis and Treatment Standards: Include a variety of drugs for type 1 preventive therapy to improve heart and kidney health
Ann Neurol: Cornell University's new discovery: cancer patients are susceptible to stroke, or due to blood hypercoagulability
Eur J Cancer: Trastuzumab-lapatinib neoadjuvant treatment of HER2+ early breast cancer patients: from the CHER-Lob study
World J Gastroenterol: Periodontitis combined with smoking increases the risk of ulcerative colitis
Relieve the patient's cardiac symptoms within two weeks Jixing Pharmaceutical owns R&D rights in Greater China
JNNP-Atrial fibrillation causes ischemic stroke, and the risk of stroke recurrence after anticoagulation is higher
Use new corrosion inhibitors to improve the corrosion resistance of coatings
GUT: Helicobacter pylori infection has an adverse effect on the efficacy of cancer immunotherapy
GUT: Proton pump inhibitors do not increase the risk of colorectal cancer
Clinical Nutrition: Body composition parameters can predict the prognosis of locally advanced gastric cancer patients after receiving neoadjuvant therapy
Lung Cancer: Efficacy and safety of dacomitinib in the first-line treatment of EGFR mutation-positive NSCLC patients in Asian population: results of phase 3 study ARCHER 1050
The second domestic manufacturer of 8 billion insulin is coming to Dongyang Pharmaceutical to follow closely
Welcome to Echemi
